Nitrosamine
NDSRI Regulatory reporting requirements and their timeline
Navigating NDSRI regulatory reporting requirements is crucial for pharmaceutical companies to ensure compliance and patient safety. These regulations mandate timely and accurate reporting of nitrosamine impurities in medicines. Understanding the timeline for these requirements helps streamline processes and avoid costly delays.
August 14, 2024
